The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response

Genes and Development

Volumn 27, Issue 16, 2013, Pages 1752-1768

  Li, Mo ^a   Lu, Lin Yu ^a   Yang, Chao Yie ^a,b   Wang, Shaomeng ^a,b   Yu, Xiaochun ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

DNA damage; PAR binding domain; Poly(ADP ribose)

Indexed keywords

ATM PROTEIN; LIGASE 4; NIBRIN; PROTEIN; PROTEIN APTX; PROTEIN PNKP; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS;

DNA DAMAGE; PAR BINDING DOMAIN; POLY(ADP-RIBOSE);

ADENOSINE DIPHOSPHATE RIBOSE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; LIGASES; MODELS, MOLECULAR; NUCLEAR PROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT;

EID: 84882724418     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.226357.113     Document Type: Article

References (107)

1. Abraham RT. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15: 2177-2196.
2. Ahel I., Ahel D, Matsusaka T, Clark AJ, Pines J, Boulton SJ, West SC. 2008. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451: 81-85.
3. Ali A.A., Jukes RM, Pearl LH, Oliver AW. 2009. Specific recognition of a multiply phosphorylated motif in the DNA repair scaffold XRCC1 by the FHA domain of human PNK. Nucleic Acids Res 37: 1701-1712.
4. Ame J.C., Spenlehauer C, de Murcia G. 2004. The PARP superfamily. Bioessays 26: 882-893.
5. Anderson L., Henderson C, Adachi Y. 2001. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 21: 1719-1729.
6. Anisimov V.M., Ziemys A, Kizhake S, Yuan Z, Natarajan A, Cavasotto CN. 2011. Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1. J Comput Aided Mol Des 25: 1071-1084.
7. Baer R. 2013. Luring BRCA1 to the scene of the crime. Cancer Cell 23: 565-567.
8. Baker N.A., Sept D, Joseph S, Holst MJ, McCammon JA. 2001. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc Natl Acad Sci 98: 10037-10041.
9. Bakkenist C.J., Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506.
10. Becherel O.J., Jakob B, Cherry AL, Gueven N, Fusser M, Kijas AW, Peng C., Katyal S, McKinnon PJ, Chen J, et al. 2010. CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response. Nucleic Acids Res 38: 1489-1503.
11. Bonner W.M., Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. 2008. gH2AX and cancer. Nat Rev Cancer 8: 957-967.
12. Callen E., Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen H.T., Faryabi RB, Polato F, Santos M, Starnes LM, et al. 2013. 53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions. Cell 153: 1266-1280.
13. Campbell S.J., Edwards RA, Glover JN. 2010. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1. Structure 18: 167-176.
14. Celeste A., Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt D.W., Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 5: 675-679.
15. Chapman J.R., Jackson SP. 2008. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep 9: 795-801.
16. Chapman J.R., Barral P, Vannier JB, Borel V, Steger M, Tomas-Loba A, Sartori AA, Adams IR, Batista FD, Boulton SJ. 2013. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol Cell 49: 858-871.
17. Chen L., Trujillo K, Sung P, Tomkinson AE. 2000. Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase. J Biol Chem 275: 26196-26205.
18. Chiu C.C., Li CH, Ung MW, Fuh TS, Chen WL, Fang K. 2005. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells. Cancer Lett 223: 249-258.
19. Cuneo M.J., Gabel SA, Krahn JM, Ricker MA, London RE. 2011. The structural basis for partitioning of the XRCC1/DNA ligase III-a BRCT-mediated dimer complexes. Nucleic Acids Res 39: 7816-7827.
20. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. 1999. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342: 249-268.
21. Darden T.A., York DM, Pedersen L. 1993. Particle mesh Ewald: An N-log(N) method for Ewald sums in large systems. J Chem Phys 98: 10089-10092.
22. DiTullio RA Jr, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J., Halazonetis TD. 2002. 53BP1 functions in an ATMdependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 4: 998-1002.
23. Dolinsky T.J., Nielsen JE, McCammon JA, Baker NA. 2004. PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32: W665-W667.
24. Durocher D., Henckel J, Fersht AR, Jackson SP. 1999. The FHA domain is a modular phosphopeptide recognition motif. Mol Cell 4: 387-394.
25. Durocher D., Taylor IA, Sarbassova D, Haire LF, Westcott SL, Jackson S.P., Smerdon SJ, Yaffe MB. 2000. The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol Cell 6: 1169-1182.
26. Fahrer J., Kranaster R, Altmeyer M, Marx A, Burkle A. 2007. Quantitative analysis of the binding affinity of poly(ADPribose) to specific binding proteins as a function of chain length. Nucleic Acids Res 35: e143.
27. Falck J., Mailand N, Syljuasen RG, Bartek J, Lukas J. 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410: 842-847.
28. Fathers C., Drayton RM, Solovieva S, Bryant HE. 2012. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells. Cell Cycle 11: 990-997.
29. Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, et al. 2002. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4: 993-997.
30. Friesner R.A., Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren T.A., Sanschagrin PC, Mainz DT. 2006. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein_ligand complexes. J Med Chem 49: 6177-6196.
31. Gagne J.P., Hendzel MJ, Droit A, Poirier GG. 2006. The expanding role of poly(ADP-ribose) metabolism: Current challenges and new perspectives. Curr Opin Cell Biol 18: 145-151.
32. Gibson B.A., Kraus WL. 2012. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13: 411-424.
33. Glover J.N., Williams RS, Lee MS. 2004. Interactions between BRCT repeats and phosphoproteins: Tangled up in two. Trends Biochem Sci 29: 579-585.
34. Goldberg M., Stucki M, Falck J, D'Amours D, Rahman D, Pappin D., Bartek J, Jackson SP. 2003. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421: 952-956.
35. Götz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC. 2012. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Theory Comput 8: 1542-1555.
36. Hirose Y., Berger MS, Pieper RO. 2001. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61: 1957-1963.
37. Horejsi Z., Falck J, Bakkenist CJ, Kastan MB, Lukas J, Bartek J. 2004. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation. Oncogene 23: 3122-3127.
38. Hottiger M.O., Hassa PO, Luscher B, Schuler H, Koch-Nolte F. 2010. Toward a unified nomenclature for mammalian ADPribosyltransferases. Trends Biochem Sci 35: 208-219.
39. Huen M.S., Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J. 2007. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131: 901-914.
40. Ibrahim Y.H., Garcia-Garcia C, Serra V, He L, Torres-Lockhart K, Prat A., Anton P, Cozar P, Guzman M, Grueso J, et al. 2012. PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA proficient triple negative breast cancer to PARP inhibition. Cancer Discov 2: 1036-1047.
41. Jones G., Willett P, Glen RC, Leach AR, Taylor R. 1997. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267: 727-748.
42. Jorgensen W.L., Chandrasekha J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
43. Juvekar A., Burga LN, Hu H, Lunsford EP, Ibrahim YH, Balmana J, Rajendran A, Papa A, Spencer K, Lyssiotis CA, et al. 2012. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for a mouse model of BRCA1-related breast cancer. Cancer Discov 2: 1048-1063.
44. Karras G.I., Kustatscher G, Buhecha HR, Allen MD, Pugieux C, Sait F., Bycroft M, Ladurner AG. 2005. The macro domain is an ADP-ribose binding module. EMBO J 24: 1911-1920.
45. Kim M.Y., Zhang T, Kraus WL. 2005. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 19: 1951-1967.
46. Kim H., Chen J, Yu X. 2007a. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316: 1202-1205.
47. Kim H., Huang J, Chen J. 2007b. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat Struct Mol Biol 14: 710-715.
48. Kobayashi J., Antoccia A, Tauchi H, Matsuura S, Komatsu K. 2004. NBS1 and its functional role in the DNA damage response. DNA Repair 3: 855-861.
49. Kolas N.K., Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney F.D., Panier S, Mendez M, Wildenhain J, Thomson TM, et al. 2007. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318: 1637-1640.
50. Kollman P.A., Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, WangW, et al. 2000. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc Chem Res 33: 889-897.
51. Kurz E.U., Lees-Miller SP. 2004. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair) 3: 889-900.
52. Lee J.H., Paull TT. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304: 93-96.
53. Li M., Yu X. 2013. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23: 693-704.
54. Li J., Williams BL, Haire LF, Goldberg M, Wilker E, Durocher D, Yaffe M.B., Jackson SP, Smerdon SJ. 2002. Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol Cell 9: 1045-1054.
55. Li GY, McCulloch RD, Fenton AL, Cheung M, Meng L, Ikura M, Koch CA. 2010. Structure and identification of ADP-ribose recognition motifs of APLF and role in the DNA damage response. Proc Natl Acad Sci 107: 9129-9134.
56. Liu Z., Wu J, Yu X. 2007. CCDC98 targets BRCA1 to DNA damage sites. Nat Struct Mol Biol 14: 716-720.
57. Lloyd J., Chapman JR, Clapperton JA, Haire LF, Hartsuiker E, Li J, Carr AM, Jackson SP, Smerdon SJ. 2009. A supramodular FHA/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage. Cell 139: 100-111.
58. Loizou J.I., El-Khamisy SF, Zlatanou A, Moore DJ, Chan DW, Qin J, Sarno S, Meggio F, Pinna LA, Caldecott KW. 2004. The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks. Cell 117: 17-28.
59. Lou Z., Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A., Manis JP, van Deursen J, Nussenzweig A, Paull TT, et al. 2006. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 21: 187-200.
60. Lukas J., Lukas C, Bartek J. 2004. Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time. DNA Repair 3: 997-1007.
61. Lukas J., Lukas C, Bartek J. 2011. More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance. Nat Cell Biol 13: 1161-1169.
62. Luo X., Kraus WL. 2012. On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 26: 417-432.
63. Mahajan A., Yuan C, Lee H, Chen ES, Wu PY, Tsai MD. 2008. Structure and function of the phosphothreonine-specific FHA domain. Sci Signal 1: re12.
64. Mailand N., Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C., Lukas J. 2007. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131: 887-900.
65. Mani R.S., Fanta M, Karimi-Busheri F, Silver E, Virgen CA, Caldecott K.W., Cass CE, Weinfeld M. 2007. XRCC1 stimulates polynucleotide kinase by enhancing its damage discrimination and displacement from DNA repair intermediates. J Biol Chem 282: 28004-28013.
66. Manke I.A., Lowery DM, Nguyen A, Yaffe MB. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302: 636-639.
67. Messner S., Hottiger MO. 2011. Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol 21: 534-542.
68. Mohammad D.H., Yaffe MB. 2009. 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair 8: 1009-1017.
69. Oberoi J., RichardsMW, Crumpler S, Brown N, Blagg J, Bayliss R. 2010. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkheadassociated and RING domains (CHFR). J Biol Chem 285: 39348-39358.
70. Olive P.L., Banath JP. 2006. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 1: 23-29.
71. Paull T.T., Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886-895.
72. Pellegrini M., Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L., Nussenzweig A. 2006. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature 443: 222-225.
73. Pleschke J.M., Kleczkowska HE, Strohm M, Althaus FR. 2000. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 275: 40974-40980.
74. Polo S.E., Jackson SP. 2011. Dynamics of DNA damage response proteins at DNA breaks: A focus on protein modifications. Genes Dev 25: 409-433.
75. Rappold I., Iwabuchi K, Date T, Chen J. 2001. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damagesignaling pathways. J Cell Biol 153: 613-620.
76. Rastelli G., Del Rio A, Degliesposti G, Sgobba M. 2010. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31: 797-810.
77. Riballo E., Woodbine L, Stiff T, Walker SA, Goodarzi AA, Jeggo PA. 2009. XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation. Nucleic Acids Res 37: 482-492.
78. Rodriguez M., Yu X, Chen J, Songyang Z. 2003. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J Biol Chem 278: 52914-52918.
79. Rungrotmongkol T., Nunthaboot N, Malaisree M, Kaiyawet N, Yotmanee P., Meeprasert A, Hannongbua S. 2010. Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and Venezuelan equine encephalitis viruses: Molecular dynamics simulations and free energy calculations. J Mol Graph Model 29: 347-353.
80. Ryckaert J-P, Ciccotti G, Berendsen HJC. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys 23: 327-341.
81. Sarkaria J.N., Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT. 1998. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 58: 4375-4382.
82. Schreiber V., Dantzer F, Ame JC, de Murcia G. 2006. Poly(ADPribose): Novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517-528.
83. Shiloh Y., Ziv Y. 2013. The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14: 197-210.
84. Shiozaki E.N., Gu L, Yan N, Shi Y. 2004. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: Implications for signaling. Mol Cell 14: 405-412.
85. Sibanda B.L., Critchlow SE, Begun J, Pei XY, Jackson SP, Blundell TL, Pellegrini L. 2001. Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol 8: 1015-1019.
86. Smith J., Tho LM, Xu N, Gillespie DA. 2010. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108: 73-112.
87. Spycher C., Miller ES, Townsend K, Pavic L, Morrice NA, Janscak P., Stewart GS, Stucki M. 2008. Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J Cell Biol 181: 227-240.
88. Stiff T., Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P., O'Driscoll M, Jeggo PA. 2006. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 25: 5775-5782.
89. Stracker T.H., Petrini JH. 2011. The MRE11 complex: Starting from the ends. Nat Rev Mol Cell Biol 12: 90-103.
90. Stucki M., Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. 2005. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123: 1213-1226.
91. Su TT. 2006. Cellular responses to DNA damage: One signal, multiple choices. Annu Rev Genet 40: 187-208.
92. Sun Z., Hsiao J, Fay DS, Stern DF. 1998. Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science 281: 272-274.
93. Wang B., Matsuoka S, Carpenter PB, Elledge SJ. 2002. 53BP1, a mediator of the DNA damage checkpoint. Science 298: 1435-1438.
94. Wang B., Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi S.P., Elledge SJ. 2007. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316: 1194-1198.
95. Wang Z., Michaud GA, Cheng Z, Zhang Y, Hinds TR, Fan E, Cong F., Xu W. 2012. Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination. Genes Dev 26: 235-240.
96. Ward I.M., Minn K, van Deursen J, Chen J. 2003. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 23: 2556-2563.
97. Whitehouse C.J., Taylor RM, Thistlethwaite A, Zhang H, Karimi-Busheri F., Lasko DD, Weinfeld M, Caldecott KW. 2001. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104: 107-117.
98. Williams R.S., Dodson GE, Limbo O, Yamada Y, Williams JS, Guenther G., Classen S, Glover JN, Iwasaki H, Russell P, et al. 2009. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 139: 87-99.
99. Wu L., Luo K, Lou Z, Chen J. 2008. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc Natl Acad Sci 105: 11200-11205.
100. Wu P.Y., Frit P, Meesala S, Dauvillier S, Modesti M, Andres SN, Huang Y., Sekiguchi J, Calsou P, Salles B, et al. 2009. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Mol Cell Biol 29: 3163-3172.
101. Wu J., Chen Y, Lu LY, Wu Y, Paulsen MT, Ljungman M, Ferguson DO, Yu X. 2011. Chfr and RNF8 synergistically regulate ATM activation. Nat Struct Mol Biol 18: 761-768.
102. Yang J., Yu Y, Hamrick HE, Duerksen-Hughes PJ. 2003. ATM, ATR and DNA-PK: Initiators of the cellular genotoxic stress responses. Carcinogenesis 24: 1571-1580.
103. Yang L., Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. 2010. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543.
104. Ying W., Sevigny MB, Chen Y, Swanson RA. 2001. Poly(ADPribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc Natl Acad Sci 98: 12227-12232.
105. Yu X., Chen J. 2004. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol Cell Biol 24: 9478-9486.
106. Yu X., Chini CC, He M, Mer G, Chen J. 2003. The BRCT domain is a phospho-protein binding domain. Science 302: 639-642.
107. Zhang X., Morera S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K., Nash RA, Sternberg MJ, Lindahl T, Freemont PS. 1998. Structure of an XRCC1 BRCT domain: A new protein-protein interaction module. EMBO J 17: 6404-6411.